Medical research

A new target for the treatment of idiopathic pulmonary fibrosis

An article published in Experimental Biology and Medicine identifies a new target for the treatment of idiopathic pulmonary fibrosis. The study, led by Dr. Huaping Dai in the Department of Pulmonary and Critical Care Medicine ...

Pediatrics

Looking for 'help' signals in the blood of newborns with HIE

Measuring a number of biomarkers over time that are produced as the body responds to inflammation and injury may help to pinpoint newborns who are more vulnerable to suffering lasting brain injury due to disrupted oxygen ...

Oncology & Cancer

Researchers find BRAF protein modification could slow tumor growth

The protein BRAF is a key player in the development of many different types of cancer, including melanoma. Scientists have known that BRAF becomes activated by growth factors and subsequently stimulates downstream proteins ...

Cardiology

Myocarditis: Overshooting the mark

Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich have shown that a protein called midkine, a member of the class of signaling molecules known as cytokines, is a key driver of inflammation in the heart muscle ...

Diseases, Conditions, Syndromes

Protection against malaria: A matter of balance

A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by the Barcelona Institute for Global Health (ISGlobal). The ...

Neuroscience

Nature of immune cells in the human brain disclosed

Researchers from the Netherlands Institute for Neuroscience and Amsterdam UMC have discovered how T cells protect the brain against harmful viruses. The results of the study, which are published in Nature Communications, ...

page 1 from 9